Accéder au contenu
Merck

Eosinophilic lung disease induced by bicalutamide: a case report and review of the medical literature.

Chest (1998-03-14)
P W Wong, N Macris, L DiFabrizio, N S Seriff
RÉSUMÉ

A 69-year-old man with advanced prostate cancer was receiving antiandrogen therapy (bicalutamide [Casodex]). He developed dyspnea, peripheral eosinophilia and bilateral pulmonary interstitial infiltrates. Transbronchial biopsy confirmed pulmonary eosinophilia. Withdrawal of bicalutamide and initiation of steroid therapy resulted in clinical improvement.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Bicalutamide (CDX), ≥98% (HPLC), powder
Bicalutamide, European Pharmacopoeia (EP) Reference Standard
Bicalutamide for system suitability, European Pharmacopoeia (EP) Reference Standard